09:44     LEE'S PHARM<08221> - Quarterly Results Announcement (2)             

                                                                              
    The adopton of other new HKFRSs does not result in substantial            
    changes to the Group's accounting policies except that certain            
    presentation and disclosure of the accounts would b affected on           
    the 2005 half year and annual reports.                                    
                                                                              
    2. Dividend                                                               
                                                                              
    The Board does not recommend the payment of any dividend for              
    the period (2004:Nil).                                                    
                                                                              
    3. Earnings (loss) per share                                              
                                                                              
    The calculation of basic and diluted earnings (loss) per share is         
    based on the following data:                                              
                                                                              
                                           For the three months ended 31.03   
                                                  2005             2004       
                                                                (restated)    
                                                                              
    Profit (loss):                                                            
    Net profit (loss) for the period                                          
      for the purpose of basic and                                            
      diluted earnings (loss) per share        HK$39,000     HK$(1,468,000)   
                                            ============      ============    
    Number of shares:                                                         
    Weighted average number of                                                
      ordinary shares for the                                                 
      purpose of basic earnings                                               
      (loss) per share                        346,225,000       289,225,000   
    Effect of dilutive potential                                              
      ordinary shares:options                                                 
      and warrants                                    -                 -     
                                             ------------      ------------   
    Weighted average number of                                                
      ordinary shares for the                                                 
      purpose of diluted earnings                                             
      (loss)per share                         346,225,000       289,225,000   
                                             ============      ============